Tarsus Pharmaceuticals Inc.
TARS | NASDAQ
$77.46
-$0.63 (-0.81%)
At close: Sep 21, 2026, 4:00 PM ET
$77.46
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -46.48M | -48.27M | -66.42M | -81.16M | -91.99M | -104.94M | -115.55M | -134.34M | -150.07M | -148.21M | -135.89M | -107.59M | -90.95M | -65.27M | -62.09M | -63.34M | -56.53M | -44.44M | -13.83M | -10.44M | -4.88M | -14.48M |
Depreciation & Amortization | 2.28M | 1.73M | 1.76M | 1.75M | 1.63M | 1.42M | 1.23M | 1.14M | 1.1M | 1.04M | 877K | 628K | 478K | 388K | 325K | 267K | 256K | 289K | 312K | 312K | 253K | 145K |
Stock-Based Compensation | 51.81M | 46.76M | 41.72M | 34.81M | 29.98M | 29.23M | 27.82M | 25.9M | 23.73M | 21.44M | 19.83M | 18.02M | 16.35M | 14.69M | 13.46M | 11.97M | 10.5M | 9.77M | 8.46M | 6.71M | 4.82M | 2.2M |
Other Working Capital | 60.07M | 38.68M | 48.53M | -12.14M | -29.15M | -4.42M | -13.73M | -6.91M | 2.28M | -1.02M | 4.3M | 761K | 1.15M | 788K | 1.49M | 1.11M | 20.26M | 211.03M | 209.54M | 210.61M | 188.42M | -3.22M |
Other Non-Cash Items | 33.64M | -3.75M | -4.15M | -4.7M | 5.17M | 7.46M | 9.21M | 9.93M | 1.09M | -717K | -2.61M | -3.29M | -3M | -1.53M | 227K | 1.83M | 1.74M | 1.22M | 6.18M | 5.78M | 8.86M | 8.84M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 350K | 1.25M | 1.25M | 1.25M | 903K | n/a |
Change in Working Capital | 38.45M | -12.93M | 14.64M | -4.66M | -25.66M | 952K | -5.73M | -2.81M | 261K | -6.88M | 306K | 3.2M | 1.84M | -3.99M | -951K | -999K | 19.12M | 32.17M | 1.37M | 2.24M | -17.78M | -27.64M |
Operating Cash Flow | 79.7M | -16.45M | -12.45M | -53.96M | -80.87M | -65.89M | -83.03M | -100.18M | -123.89M | -133.31M | -117.49M | -89.03M | -75.28M | -55.71M | -49.03M | -50.28M | -24.55M | 256K | 3.75M | 5.86M | -7.83M | -30.94M |
Capital Expenditures | -18.16M | -15.09M | -9.86M | -8.57M | -6.95M | -6.98M | -6.57M | -1.5M | -5.59M | -5.34M | -5.5M | -5.63M | -1.35M | -685K | -506K | -653K | -678K | -572K | -586K | -312K | -326K | -645K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -267.98M | -395.29M | -394.06M | -447.57M | -369.33M | -289.65M | -268.63M | -178.66M | -154.57M | -104.55M | -28.66M | -121.07M | -178.11M | -178.11M | -149.44M | -57.03M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 309.99M | 344.64M | 361.8M | 305.18M | 230.18M | 161.72M | 73M | 55.39M | 82.63M | 136.97M | 174.77M | 156.92M | 105.18M | 40.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -5M | -2M | -2M | -2M | 3M | -4M | -4M | -4M | 1.32M | 5.32M | 5.32M | 5.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 23.85M | -65.74M | -42.12M | -150.96M | -143.09M | -131.91M | -199.2M | -121.77M | -77.53M | 27.09M | 140.6M | 35.54M | -68.96M | -133.17M | -144.63M | -57.68M | -678K | -572K | -586K | -262K | -276K | -595K |
Debt Repayment | n/a | n/a | n/a | -31.88M | -31.92M | 39.6M | 39.6M | 71.48M | 76.52M | 5M | 10M | 10M | 5M | 4.94M | 19.13M | 19.13M | 19.13M | 19.19M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.3M | n/a | n/a | 31.88M | 31.88M | n/a | n/a | -31.88M | -31.88M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -99K | 36K |
Financial Cash Flow | 9.61M | 8.03M | 143.39M | 144M | 142.08M | 182.45M | 154.66M | 171.49M | 275.74M | 233.93M | 130.18M | 110.68M | 5.65M | 79.88M | 93.99M | 93.65M | 93.86M | 19.13M | 21K | 91.86M | 131.68M | 131.82M |
Net Cash Flow | 113.16M | -74.16M | 88.82M | -60.92M | -81.88M | -15.36M | -127.57M | -50.46M | 74.32M | 127.71M | 153.29M | 57.18M | -138.59M | -109.01M | -99.67M | -14.31M | 68.63M | 18.81M | 3.18M | 97.45M | 123.58M | 100.29M |
Free Cash Flow | 61.55M | -31.54M | -22.31M | -62.54M | -87.82M | -72.87M | -89.59M | -101.68M | -129.48M | -138.65M | -123M | -94.66M | -76.63M | -56.4M | -49.54M | -50.93M | -25.23M | -316K | 3.16M | 5.59M | -8.1M | -31.53M |
Adj. Free Cash Flow | 9.73M | -78.3M | -64.03M | -97.35M | -117.8M | -102.1M | -117.41M | -127.57M | -153.21M | -160.09M | -142.83M | -112.68M | -92.98M | -71.09M | -63M | -62.9M | -35.74M | -10.08M | -5.29M | -1.12M | -12.92M | -33.73M |
Maintenance CapEx | -3.98M | -2.98M | -2.55M | -2.98M | -2.98M | -2.98M | -2.98M | n/a | -4.22M | -5.01M | -5.19M | -5.19M | -1.06M | -397.06K | -379K | -633.14K | -585.28K | -463.28K | -302.28K | -48.14K | -24K | -41K |
Growth CapEx | -14.17M | -12.1M | -7.31M | -5.59M | -3.96M | -4M | -3.58M | -1.5M | -1.37M | -327.55K | -314.49K | -441.49K | -287.94K | -287.94K | -127K | -19.86K | -92.72K | -108.72K | -283.72K | -263.86K | -302K | -604K |
Owner Earnings | 75.72M | -19.44M | -15M | -56.95M | -83.85M | -68.87M | -86.01M | -100.18M | -128.11M | -138.32M | -122.68M | -94.22M | -76.34M | -56.11M | -49.41M | -50.91M | -25.14M | -207.28K | 3.45M | 5.81M | -7.85M | -30.98M |
Add to Watchlist
Select watchlists to add or remove TARS